Our Pipeline

PreciseOligo Dx series for Neurodegeneration Plasma Diagnostics：

• NeuroGuard Plasma Test
  Swiftly and precisely identify neurodegenerative diseases, with a focus on ALS, PD and AD.
• AmyloOligo Test
  A specialized tool for qualitative detection of specific amyloid oligomers in plasma, aiding in the diagnosis of neurodegenerative diseases like ALS, PD, AD, FTLD, and LATE.
• Cross-β Alert Plasma Test
  Qualitatively detect specific cross-β low complexity proteins in the plasma of patients with suspected ALS, PD, AD, FTLD and LATE.

Reprofold®: a pharmacological chaperone that represents a significant advancement in halting the progression of neurodegenerative diseases in a patient. 

With promising pilot clinical trial results, Reprofold® has shown the potential for cognitive preservation and symptom reduction (see Our Science).
Invitation for Participation in Clinical Research: Soliciting Individuals Diagnosed with Early-Stage Dementia with Lewy Bodies (DLB) and Persons Aged 60 to 65 with a Familial History of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Doubleplay-1 and -2：Drugs candidates designed as Universal Virus Cleaners.